96 filings
Page 2 of 5
8-K
ixsvbuw9 8gje
13 Sep 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
lnp0xjm8y0eon7ki
12 Aug 13
Uroplasty Appoints Brett Reynolds As Chief Financial Officer
12:00am
8-K
7yv7t3q 2mu
3 Jul 13
Uroplasty Receives NASDAQ Listing Compliance Letter
12:00am
8-K
t5ayi3osnrg kb
14 Jun 13
Uroplasty Announces Delay in Filing Form 10-K
12:00am
8-K
64txurv hh
30 May 13
Uroplasty Reports Fiscal Fourth Quarter and Full Year 2013
12:00am
8-K
qoioocu3onmzkey2dxoh
5 Apr 13
Uroplasty Announces Ceo Resignation
12:00am
8-K
f5vtc4xdbvs
17 Sep 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
mwodq 4lfe
3 Oct 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
s710rd67
26 Apr 11
Departure of Directors or Certain Officers
12:00am
8-K
61k1f8 v8xa
10 Jan 11
Uroplasty Provides Update on Third Quarter Fiscal 2011 Revenue
12:00am
8-K
cg0lbycz
8 Dec 10
Uroplasty Announces Addition of Robert Kill to Its Board of Directors
12:00am
8-K
buht4t3shgmw 622s
20 Sep 10
Submission of Matters to a Vote of Security Holders
12:00am
8-K
h2c67jeee 1wil
22 Jul 10
Other Events
12:00am
8-K
wbd o2v4xxnpq7w8lsnj
30 Jun 10
Uroplasty, Inc. to begin trading on NASDAQ Capital Markets
12:00am
8-K
19p2ddf
1 Jun 10
Uroplasty Reports Improved Financial Performance for Fourth Quarter FY2010
12:00am
8-K
n5c469ih9i6x 0wohhd
27 May 10
Unregistered Sales of Equity Securities
12:00am
8-K
9635i
4 Mar 10
SUmiT TRIAL RESULTS CLEARLY DEMONSTRATE THERAPEUTIC EFFECT OF PERCUTANEOUS TIBIAL NERVE STIMULATION
12:00am
8-K
m7xe1fcr4fg
1 Feb 10
Uroplasty Reports Results for Third Quarter FY2010
12:00am
8-K
dl3kh09wd22 m3
20 Nov 09
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
8mvhqqq
2 Nov 09
Uroplasty Reports Results for Second Quarter FY2010
12:00am